DPP4
Dipeptidyl peptidase 4
Also known as: ADCP2, CD26, DPP4_HUMAN, DPPIV
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P27487
- Gene
- DPP4
- Ensembl
- ENSG00000197635
- Chromosome
- 2
- Canonical length
- 766 aa
- Protein class
- CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The DPP4 gene encodes dipeptidyl peptidase 4, which is identical to adenosine deaminase complexing protein-2, and to the T-cell activation antigen CD26. It is an intrinsic type II transmembrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides. Dipeptidyl peptidase 4 is highly involved in glucose and insulin metabolism, as well as in immune regulation. This protein was shown to be a functional receptor for Middle East respiratory syndrome coronavirus (MERS-CoV), and protein modeling suggests that it may play a similar role with SARS-CoV-2, the virus responsible for COVID-19. [provided by RefSeq, Apr 2020]
Canonical amino-acid sequenceUniProt
766 residues, UniProt reviewed canonical sequence.
>P27487|DPP4
1 MKTPWKVLLG LLGAAALVTI ITVPVVLLNK GTDDATADSR KTYTLTDYLK NTYRLKLYSL
61 RWISDHEYLY KQENNILVFN AEYGNSSVFL ENSTFDEFGH SINDYSISPD GQFILLEYNY
121 VKQWRHSYTA SYDIYDLNKR QLITEERIPN NTQWVTWSPV GHKLAYVWNN DIYVKIEPNL
181 PSYRITWTGK EDIIYNGITD WVYEEEVFSA YSALWWSPNG TFLAYAQFND TEVPLIEYSF
241 YSDESLQYPK TVRVPYPKAG AVNPTVKFFV VNTDSLSSVT NATSIQITAP ASMLIGDHYL
301 CDVTWATQER ISLQWLRRIQ NYSVMDICDY DESSGRWNCL VARQHIEMST TGWVGRFRPS
361 EPHFTLDGNS FYKIISNEEG YRHICYFQID KKDCTFITKG TWEVIGIEAL TSDYLYYISN
421 EYKGMPGGRN LYKIQLSDYT KVTCLSCELN PERCQYYSVS FSKEAKYYQL RCSGPGLPLY
481 TLHSSVNDKG LRVLEDNSAL DKMLQNVQMP SKKLDFIILN ETKFWYQMIL PPHFDKSKKY
541 PLLLDVYAGP CSQKADTVFR LNWATYLAST ENIIVASFDG RGSGYQGDKI MHAINRRLGT
601 FEVEDQIEAA RQFSKMGFVD NKRIAIWGWS YGGYVTSMVL GSGSGVFKCG IAVAPVSRWE
661 YYDSVYTERY MGLPTPEDNL DHYRNSTVMS RAENFKQVEY LLIHGTADDN VHFQQSAQIS
721 KALVDVGVDF QAMWYTDEDH GIASSTAHQH IYTHMSHFIK QCFSLPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DPP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 147 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 147 nTPM
- small intestine: 130 nTPM
- placenta: 126 nTPM
- duodenum: 101 nTPM
- prostate: 101 nTPM
- kidney: 89 nTPM
Single-cell type
- prostatic glandular cells: 367 nCPM
- enterocytes: 348 nCPM
- syncytiotrophoblasts: 238 nCPM
- cytotrophoblasts: 203 nCPM
- salivary acinar cells: 191 nCPM
- migrating cytotrophoblasts: 186 nCPM
Immune cell
- MAIT T-cell: 52 nTPM
- memory CD4 T-cell: 16 nTPM
- naive CD4 T-cell: 16 nTPM
- memory CD8 T-cell: 11 nTPM
- gdT-cell: 6.6 nTPM
- naive CD8 T-cell: 6.6 nTPM
Brain region
- thalamus: 1.5 nTPM
- cerebral cortex: 1.1 nTPM
- white matter: 0.7 nTPM
- pons: 0.5 nTPM
- basal ganglia: 0.2 nTPM
- medulla oblongata: 0.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DPP4.
Disease | ImmuneIEDB
Conditions an epitope on DPP4 was assayed in.
- multiple sclerosis B cell
- amyotrophic lateral sclerosis B cell
- neuromyelitis optica B cell
ReferencesPubMed · IEDB
Publications for DPP4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
9 publications
- Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism.
2003 · Int J Immunopathol Pharmacol · RCR 2.5 · 89 citations - Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis.
1990 · Lab Invest · RCR 1.3 · 48 citations - CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context.
2020 · Dis Markers · RCR 0.7 · 14 citations - Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest.
2017 · Clin Biochem · RCR 0.5 · 13 citations - Renal immunopathology in murine host-versus-graft disease.
1991 · Kidney Int · RCR 0.5 · 21 citations
Show 4 more
- A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
2017 · Biomed Pharmacother · RCR 0.3 · 8 citations - Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients.
2022 · Arch Immunol Ther Exp (Warsz) · RCR 0.2 · 3 citations - Phenotypic analysis of CD26+ peripheral blood monocytes and dendritic cells in rheumatoid arthritis patients under immunomodulatory therapies.
2026 · Sci Rep - Elevated autoantibodies against dipeptidyl peptidase-4 are associated with poor prognosis in patients with type 2 diabetes.
2026 · Endocr J
Reference: B cellIEDB
1 publication
- High heterogeneity of cross-reactive immunoglobulins in multiple sclerosis presumes combining of B-cell epitopes for diagnostics: a case-control study.
2024 · Front Immunol · RCR 0.9 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.62
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.79
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- behavioral fear response
- cell adhesion
- endothelial cell migration
- locomotory exploration behavior
- membrane fusion
- negative regulation of extracellular matrix disassembly
- negative regulation of neutrophil chemotaxis
- peptide hormone processing
- positive regulation of cell population proliferation
- proteolysis
- psychomotor behavior
- receptor-mediated endocytosis of virus by host cell
- receptor-mediated virion attachment to host cell
- regulation of cell-cell adhesion mediated by integrin
- response to hypoxia
- symbiont entry into host cell
- T cell activation
- T cell costimulation
- glucagon processing
Molecular functions
- aminopeptidase activity
- chemorepellent activity
- dipeptidyl-peptidase activity
- identical protein binding
- protease binding
- protein homodimerization activity
- serine-type endopeptidase activity
- serine-type peptidase activity
- signaling receptor binding
- virus receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DPP4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DPP4 as an antibody target. Whether an autoantibody or antibody against DPP4 could matter depends on whether native DPP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DPP4 is annotated at the cell surface, where native DPP4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label DPP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...